Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2025 Earnings Call Transcript - Insider Monkey
9 hours ago • Google News
Nautilus Biotechnology Inc (NAUT)
US$ 2.49-6.39%
Price Chart
Key Statistics
Market Cap
$ 96.41M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
159.3K
52W High
$ 3.09
52W Low
$ 0.66
Dividend Yield
0.00%
Beta
1.24
Technicals
50-Day MA
0.7521
200-Day MA
1.4093
52 Week High
3.09
52 Week Low
0.66
About NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
Employees
134
Headquarters
Seattle, WA
CEO
Mr. Sujal M. Patel
Latest News
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results - Stock Titan
2 days ago • Google News
Nautilus NAUT 2025Q2 Earnings Preview Downside Ahead on Projected EPS Decline - AInvest
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg